Six Months of Hydroxyurea Reduces Albuminuria in Patients with Sickle Cell Disease

The earliest symptom of glomerular injury in patients with sickle cell disease (SCD) is microalbuminuria. The effect of hydroxyurea (HU) on urine albumin-to-creatinine ratio (ACR) is unclear and should be determined, because increasing numbers of patients with SCD take this drug to improve red blood...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Am Soc Nephrol
Auteurs principaux: Bartolucci, Pablo, Habibi, Anoosha, Stehlé, Thomas, Di Liberto, Gaetana, Rakotoson, Marie Georgine, Gellen-Dautremer, Justine, Loric, Sylvain, Moutereau, Stéphane, Sahali, Dil, Wagner-Ballon, Orianne, Remy, Philippe, Lang, Philippe, Grimbert, Philippe, Audureau, Etienne, Godeau, Bertrand, Galacteros, Frédéric, Audard, Vincent
Format: Artigo
Langue:Inglês
Publié: American Society of Nephrology 2016
Sujets:
Clinical Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4884099/
https://ncbi.nlm.nih.gov/pubmed/26586692
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2014111126
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires